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Introduction
Pain is the commonest symptom of rheumatic disease. Most patients would seek medical attention when pain is disturbing. When chronic pain is not satisfactorily managed it may lead to a change in personality, life style, functional ability, depression and sleep disturbance", The management of pain in rheumatic conditions depends on a multidisciplinary team approach, yet relieving the suffering of some patients with chronic pain remains difficult and often inadequate. Many of these patients will, unfortunately, resort to hypnotics to overcome their insomnia. There is growing concern over the excessive use of benzodiazepines (BDP). Several reports recently highlighted the risk of dependance and withdrawal symptoms-:", Of 106 patients admitted to the John Hopkins chronic pain treatment centre, 64 (60%) were taking benzodiazepines". In this study we shall describe the use of BDP in patients with arthritis attending the rheumatology clinic. 
Number of cases Inflammatory arthritis Osteoarthritis

Method
One hundred and twenty-seven consecutive patients attending the rheumatology clinic in a district general hospital were questioned with regard to the type and severity of arthritis, the degree of their pain and usage of drugs including hypnotics. The arthritis was classified as inflammatory (rheumatoid arthritis and ankylosing spondylitis) and non-inflammatory (osteoarthritis). The severity of the arthritis was clinically graded into: mild (early), moderate and severe (deforming). Pain is notoriously difficult to assess objectively; we therefore adopted the simple grading technique of: none, mild, moderate and severe. The time of pain was recorded (day and night). The drug history was recorded including the use of benzodiazepines, non-steroidal anti-inflammatory drugs, analgesics and second line therapy. When hypnotics were taken, specific questions were asked including dosage, frequency, duration of therapy, purpose for taking, side effects, if any, and whether therapy was initiated by hospital or the general practitioner. Patients were grouped into BDP users (when night sedation was taken) and non-BDP users. Particular attention was paid to discover whether BDPs were prescribed to alleviate paininduced insomnia. Enquiries were made about smoking, alcohol, and whether other members of the family were also taking hypnotics. Statistical methods used were Student's t-test represented using 95% confidence intervals and the chi-squared test.
Results
The majority of patients 102 (80%) were classified as classical/definite rheumatoid arthritis. Four patients with ankylosing spondylitis were included in the inflammatory group. Twenty-one patients had osteoarthritis (Table 1) .
Thirty-seven patients (29%)were taking BDP (mean duration 4.1 years, SEM 0.56), of whom 34 (92%)were women ( Table 2) . Significantly more women than men were taking BDP (chi square 11.89, P<O.OOl). The BDP users were significantly older than those not taking BDP (t=2.49, P< 0.05). There was no significant 0141-0768/91/ 020073-03/$02.00/0 © 1991 The Royal Society of Medicine Table 3 . Summary of the drug consumption of the patients in the study difference (P> 0.05) between the groups in respect of the number of patients with inflammatory arthritis, severe arthritis, or those reporting mild to moderate pain. In the BDP group more patients complained of night pain (chi square 11.98, P<O.OOl), and more patients reported severe pain (chi square 11.87, P<O.OOl).
In the BDP group, there was significantly more use of narcotic analgesics -codeine with propoxyphene (chi square 9.4, P< 0.01), whilst fewer patients took NSAIDS (Chi square 12.4, P<O.OOl) ( Table 3 ). In patients with inflammatory arthritis there was no significant difference in the usage of second line agents (chi square 0.169, P>0.05).
Side effects to BDP were common ( Table 4 ); 11% of patients (4/37) reported side effects such as morning headache, lethargy and lack of concentration. Only two patients had attempted to discontinue these drugs and both experienced withdrawal effects. None of the patients who took intermittent night sedation (1-3 times a week) experienced side effects. The BDPs taken by the patients are given in Table 5 .
In the BDP group, eight patients were taking hypnotics not in association with night pain, four of them for anxiety and depression, the other four did not know why they were taking them.
An interesting finding was most patients did not volunteer that they were taking BDP. Three patients admitted that their spouses were also taking night sedation. When interviewed, the majority of patients on BDP wanted to try and stop the treatment, only one woman aged 76 years with severe rheumatoid arthritis refused saying 'at my age quality of life is far more important than the risk of becoming addicted to sleeping tablets'.
Discussion
The results of this study are alarming. They demonstrate that the misuse of BDP amongst arthritic patients is common. Long-term use of BDP has been associated with impaired psychomotor and psychological performances's", short term memory deficits'' and blunting of emotional response'', A population survey in England in 1984 showed that 3% of all adults were taking BDP for more than one year!". Over the age of 65 years, the prevalence of BDP use increases to 16%11. In our study 39% of patients in this age group were taking BDP. We have shown that those who take night sedation tend to be women above the age of 60 years with more severe pain. Other reports have also shown that women take hypnotics more frequently than men 12,13. We are unable to explain why more women than men take hypnotics in rheumatic disease. One possibility is that women have a low threshold of pain, therefore display a high level of somatic anxiety, or it may be that the severe pain is not adequately controlled, therefore only a combination ofBDP and narcotics is effective in facilitating sleep. Further research is needed into the relationship between arthritic pain and insomnia to obtain more information about the history, frequency, duration and the link with the disease activity. In this study 70% of BDP were prescribed by general practitioners, a finding supported by earlier reports which showed that BDP and antidepressants are the two most commonly prescribed groups of psychotropic drugs used in general practice 13.14. Certainly some patients with chronic anxiety disorder or insomnia would require treatment with BDp15. 16 . We therefore recommend the following strategies: (1) pain should be thoroughly assessed and treated using medical, surgical and physiotherapy methods prior to the introduction of benzodiazepines. (2) the use of narcotic analgesia should be carefully monitored. (3) as hypnotics, BDP should be used to treat insomnia only when it is severe, disabling, disturbing or subjecting the individual to extreme distress'I:".
In our patients no counselling had been offered prior to commencement of BDP. (4) in selected cases when night pain is severe and constant, there may be a case for BDP prescribing (less than 2 weeks) under medical supervision pending a medical or surgical means to alleviate the pain. In summary, this work emphasizes the importance of pain control in arthritis. To avoid the risk of BDP abuse, a multidisciplinary team approach including hospital and community assessment would be both valuable and practical, particularly for the high risk group (older women with severe pain who concomitantly take narcotic analgesia).
